March 22, 2017 / 11:12 AM / 4 months ago

BRIEF-FDA grants fast track designation for Shire's Recombinant Adamts13

1 Min Read

March 22 (Reuters) - Shire Plc -

* Shire Plc - United States Food And Drug Administration (FDA) has granted fast track designation for Recombinant Adamts13

* Will initiate its phase 3 trial with SHP655 as a randomized, open-label, 2-period crossover study with a single arm continuation Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below